Related Experiment Video
Updated: Apr 11, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Host-directed microRNA-based intervention against intracellular Staphylococcus aureus: high-throughput screening
Pablo Castañera1, Jesús Llano-Verdeja1, Helena Á Ferrero1
1Departamento de Biología Molecular, Área de Microbiología, Universidad de León, León, Spain.
Background:
The intracellular persistence of Staphylococcus aureus remains a major therapeutic challenge, enabling immune evasion and reducing the efficacy of antibiotics with limited intracellular activity. Host-directed therapies, particularly those based on microRNAs (miRNAs), represent a promising strategy to overcome these limitations.
Methods:
We performed a high-throughput screen of 2,469 human miRNA mimics in A549 epithelial cells infected with S. aureus USA300. Candidate miRNAs were prioritised using network centrality analysis and validated across different S. aureus strains and epithelial cell lines. RNA-seq profiling was conducted to examine host responses.
Results:
From this screen, ten candidates were identified, of which miR-4430, miR-1249-5p, and miR-147a consistently reduced intracellular bacterial burden and protected host cells. Transcriptomic analysis revealed complementary pathway-level programs: miR-4430 enhanced innate immune pathways, including STAT1- and PTAFR-associated signalling programs, while miR-1249-5p and miR-147a modulated extracellular matrix organisation and integrin-mediated adhesion, thereby interfering with bacterial entry.
Discussion:
These findings highlight a coordinated host defence strategy in which miR-4430 calibrates immune responses, while miR-1249-5p and miR-147a remodel host adhesion machinery. Together, they elicit complementary pressures that transiently reduce S. aureus intracellular proliferation and promote bacterial clearance. Our results underscore the therapeutic potential of miRNA-based host-directed interventions, which may be combined with conventional antibiotics to limit infection and resistance development.
Insights
microRNAs (miRNAs) offer a novel host-directed therapy against persistent Staphylococcus aureus infections. Specific miRNAs reduce bacterial burden and enhance immune responses, showing potential for combination treatments to combat antibiotic resistance.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Intracellular Staphylococcus aureus persistence poses a significant therapeutic challenge, contributing to immune evasion and reduced antibiotic efficacy.
- Host-directed therapies utilizing microRNAs (miRNAs) present a promising strategy to overcome these limitations.
Purpose of the Study:
- To identify specific human miRNAs that can reduce intracellular Staphylococcus aureus burden and enhance host defense mechanisms.
- To explore the mechanisms by which these identified miRNAs modulate host responses to S. aureus infection.
Main Methods:
- A high-throughput screen of 2,469 human miRNA mimics was performed in A549 epithelial cells infected with S. aureus USA300.
- Candidate miRNAs were prioritized using network centrality analysis and validated across different S. aureus strains and epithelial cell lines.
- RNA-sequencing (RNA-seq) profiling was conducted to examine host responses.
Main Results:
- Ten candidate miRNAs were identified, with miR-4430, miR-1249-5p, and miR-147a consistently reducing intracellular bacterial burden and protecting host cells.
- Transcriptomic analysis revealed that miR-4430 enhances innate immune pathways (e.g., STAT1, PTAFR signaling).
- miR-1249-5p and miR-147a were found to modulate extracellular matrix organization and integrin-mediated adhesion, interfering with bacterial entry.
Conclusions:
- A coordinated host defense strategy involving miR-4430 (immune calibration) and miR-1249-5p/miR-147a (remodeling adhesion) was identified.
- These miRNAs elicit complementary pressures that reduce S. aureus intracellular proliferation and promote bacterial clearance.
- miRNA-based host-directed interventions hold therapeutic potential, especially when combined with conventional antibiotics, to limit infection and combat resistance development.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
MicroRNAs
MicroRNAs
Microbial Corrosion
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi

